Following IL-6 treatment, the cell viability of ESCC cells was notably increased, but this effect was reversed when GA was added, whereas both S31-201 and DAPT could further enhance the effect of GA (Fig. 3A). The gene discussed is IL6; the disease is esophageal squamous cell carcinoma.